A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 5,224 shares of CORT stock, worth $349,590. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,224
Previous 5,146 1.52%
Holding current value
$349,590
Previous $238,000 10.5%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 10, 2025

BUY
$44.66 - $60.85 $3,483 - $4,746
78 Added 1.52%
5,224 $263,000
Q3 2024

Oct 23, 2024

BUY
$29.51 - $46.26 $151,858 - $238,053
5,146 New
5,146 $238,000

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $7.17B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Wealth Enhancement Advisory Services, LLC Portfolio

Follow Wealth Enhancement Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Enhancement Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Enhancement Advisory Services, LLC with notifications on news.